943 related articles for article (PubMed ID: 26659560)
1. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
2. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication.
Lee JS; Lee YN; Lee YT; Hwang HS; Kim KH; Ko EJ; Kim MC; Kang SM
Nutrients; 2015 Feb; 7(2):1021-36. PubMed ID: 25658239
[TBL] [Abstract][Full Text] [Related]
3. Cellular fatty acid synthase is required for late stages of HIV-1 replication.
Kulkarni MM; Ratcliff AN; Bhat M; Alwarawrah Y; Hughes P; Arcos J; Loiselle D; Torrelles JB; Funderburg NT; Haystead TA; Kwiek JJ
Retrovirology; 2017 Sep; 14(1):45. PubMed ID: 28962653
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of ginseng extract against respiratory syncytial virus infection.
Lee JS; Ko EJ; Hwang HS; Lee YN; Kwon YM; Kim MC; Kang SM
Int J Mol Med; 2014 Jul; 34(1):183-90. PubMed ID: 24756136
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028).
Sudo K; Konno K; Watanabe W; Shigeta S; Yokota T
Microbiol Immunol; 2001; 45(7):531-7. PubMed ID: 11529559
[TBL] [Abstract][Full Text] [Related]
7. Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter.
Noton SL; Nagendra K; Dunn EF; Mawhorter ME; Yu Q; Fearns R
J Virol; 2015 Aug; 89(15):7786-98. PubMed ID: 25995255
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
[TBL] [Abstract][Full Text] [Related]
9. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
[TBL] [Abstract][Full Text] [Related]
10. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium.
Mirabelli C; Jaspers M; Boon M; Jorissen M; Koukni M; Bardiot D; Chaltin P; Marchand A; Neyts J; Jochmans D
J Antimicrob Chemother; 2018 Jul; 73(7):1823-1829. PubMed ID: 29596680
[TBL] [Abstract][Full Text] [Related]
11. Tangeretin from Citrus reticulate Inhibits Respiratory Syncytial Virus Replication and Associated Inflammation in Vivo.
Xu JJ; Liu Z; Tang W; Wang GC; Chung HY; Liu QY; Zhuang L; Li MM; Li YL
J Agric Food Chem; 2015 Nov; 63(43):9520-7. PubMed ID: 26468759
[TBL] [Abstract][Full Text] [Related]
12. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells.
Khan NA; Singla M; Samal S; Lodha R; Medigeshi GR
mSphere; 2020 May; 5(3):. PubMed ID: 32461278
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes.
Chang YC; Chow YH; Sun HL; Liu YF; Lee YT; Lue KH; Ko JL
Antiviral Res; 2014 Oct; 110():124-31. PubMed ID: 25131377
[TBL] [Abstract][Full Text] [Related]
14. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.
Lee BH; Chathuranga K; Uddin MB; Weeratunga P; Kim MS; Cho WK; Kim HI; Ma JY; Lee JS
J Microbiol; 2017 Jun; 55(6):488-498. PubMed ID: 28551874
[TBL] [Abstract][Full Text] [Related]
15. FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression.
Heuer TS; Ventura R; Mordec K; Lai J; Fridlib M; Buckley D; Kemble G
EBioMedicine; 2017 Feb; 16():51-62. PubMed ID: 28159572
[TBL] [Abstract][Full Text] [Related]
16. Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection.
Davis IC; Lazarowski ER; Chen FP; Hickman-Davis JM; Sullender WM; Matalon S
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):379-86. PubMed ID: 17541010
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA.
Atreya PL; Kulkarni S
Virology; 1999 Sep; 261(2):227-41. PubMed ID: 10497108
[TBL] [Abstract][Full Text] [Related]
18. The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin.
Kim YI; Pareek R; Murphy R; Harrison L; Farrell E; Cook R; DeVincenzo J
Influenza Other Respir Viruses; 2017 Nov; 11(6):525-530. PubMed ID: 28990339
[TBL] [Abstract][Full Text] [Related]
19. Anti-Respiratory Syncytial Virus Activity of
Chathuranga K; Kim MS; Lee HC; Kim TH; Kim JH; Gayan Chathuranga WA; Ekanayaka P; Wijerathne HMSM; Cho WK; Kim HI; Ma JY; Lee JS
Viruses; 2019 Jul; 11(7):. PubMed ID: 31277257
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.
Davis IC; Lazarowski ER; Hickman-Davis JM; Fortenberry JA; Chen FP; Zhao X; Sorscher E; Graves LM; Sullender WM; Matalon S
Am J Respir Crit Care Med; 2006 Mar; 173(6):673-82. PubMed ID: 16387801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
